Menopause And Andropause Drugs Flashcards
Andropuase
Male menopause
Dysuria
Painful urinarions
Menarche
Age of onset of first menstruation
Menopause
The cessation of menstruation, end of monthly cycles, referring to the fertility cycle of women
Neurogenic
Bladder impaired bladder function caused by a nervous system abnormality, typically an injury to the spinal cord
Nocturia
Voiding at night
Overactive bladder syndrome (OBS)
Conditions of urgency, frequency, and nocturia, with or without incontinence
Stress incontinence
Losing urine without meaning to during physical activity
Urge incontinence
Sting, sudden need to void because of bladder spasm or contraction
Uroselective
Anti adrenergic drug that is selective for alpha receptors in the urinary system and not generalized
Menopause symptoms
Hot flashes, night sweats, vaginal dryness, painful intercourse, mood changes and sleep problems, vaginal walls become thinner, shorter and lose elasticity, more susceptible to yeast infections, stress incontinence due to weakening pelvic floor muscles
Estrogen in postmenopausal women uses
Relief of moderate to severe symptoms of menopause (flushing and sweating), atrophic vaginitis, osteoporosis is postmenopausal women, palliative treatment of advanced prostatic carcinoma, selected cases of advanced breast carcinoma, uterine bleeding caused by hormonal imbalance. If uterus intact, also use progestin
Transdermal estradiol in post menopausal women uses
After removal of the ovaries in postmenopausal, and primary ovarian failure
Warning swith the administration of estrogen in postmenopausal women
Increased risk of endometrial cancer, gallbladder disease, hypertension, hepatic adenoma, cardiovascular disease, thromboembolic disease, and hypercalcemia in people with breast cancer and bone metases
selective estrogen receptor modulators aka SERMs MOA
May potentiate or block estrogen effects in different tissues
SERMs in aging women uses
Vaginal atrophy, osteoporosis prevention, breast cancer treatment
Tamoxifen use
Breast cancer
Tormifene use
Breast cancer
Raloxifene MOA
Works in the bone at the estrogen receptor and decreases resorption and increases mineral density
Ospemifene use
Painful intercourse caused by vaginal atrophy
SERMS side ffects
Hot flashes, vaginal discharge, muscle spasms and excessive sweating
SERMs interactions
estrogen based drugs increase risk of endometrial cancer
SERMs in menopausal women considerations
Increased risk of deep vein thrombosis (DVT), stroke and MI
Ospmifene contraindications
Breast cancer, hepatic disease, shouldn’t be given with estrogens, estrogen antagonists, fluconazole or rifampin
SERM contraindications
Pregnancy
Raloxifene interactions
Decreased effectiveness of cholestyramine and warfarin, and drug should be discontinued 72 hours before surgical procedures
Symptoms of overactive bladder syndrome
Urinary urgency, frequent urination throughout the day and night, and urge incontinence
Antipasmodics MOA
Cholinergic blocking, inhibit bladder contractions and delay the urge to void (act at the parasympathetic nerve receptors)
Flavoxate use
In men to relieve dysuria symptoms, urinary urgency, nocturia, suprapubic pain and frequency and urge incontinence
Mirabegron MOA
Beta 3 adrenergic receptor Agonist, relaxes the smooth muscle as the bladder fills with urine, allowing the bladder to hold a greater amount of urine